Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Prevention of Nausea and Vomiting in Oxaliplatin-Treated GI Malignancy
NCT02550119Terminated
- Sponsor
- University of Southern California
- Start
- Apr 2006
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Arm I (Aprepitant) with Arm II (Placebo) (2 arms). Primary endpoint: Proportion of patients with complete response at 24 hours. Started Apr 2006; status: terminated.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02550119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02550119.